StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$44.84−1.52 (-3.28%)

Close on Nov 17, 2026Market cap $3.20BP/E –Yield –

Pulse Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Pulse Biosciences's total debt was $0 at Dec 31, 2023. For fiscal 2023 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$65.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$65.00M–
Q4 FY2022Dec 31, 2022$65.00M–
Q1 FY2021Mar 31, 2021$41.00M–

More Pulse Biosciences figures

See a number that looks wrong?